ES2158898T3 - Composiciones para la administracion de desmopresina por via nasal. - Google Patents

Composiciones para la administracion de desmopresina por via nasal.

Info

Publication number
ES2158898T3
ES2158898T3 ES94920618T ES94920618T ES2158898T3 ES 2158898 T3 ES2158898 T3 ES 2158898T3 ES 94920618 T ES94920618 T ES 94920618T ES 94920618 T ES94920618 T ES 94920618T ES 2158898 T3 ES2158898 T3 ES 2158898T3
Authority
ES
Spain
Prior art keywords
composition
administration
desmopresin
compositions
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94920618T
Other languages
English (en)
Inventor
Alan Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Application granted granted Critical
Publication of ES2158898T3 publication Critical patent/ES2158898T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

UNA COMPOSICION ACUOSA PARA LA ADMINISTRACION NASAL POR PULVERIZACION DE UN ANALOGO SINTETICO DE LA VASOPRESINA (DESMOPRESINA; 1-DESAMINO-8-D-ARGININ-VASOPRESINA) QUE CONTIENE ENTRE 2,5 Y 7,5 {MI}G POR 100 {MI}L. LA COMPOSICION PUEDE CONTENER ADICIONALMENTE UN AGENTE CONTROLADOR DE LA PRESION OSMOTICA, TAL COMO CLORURO SODICO, UN CONSERVANTE, TAL COMO CLOROBUTANOL O CLORURO DE BENZALCONIO Y UN TAMPON QUE ESTABILIZA EL PH ENTRE 4 APROXIMADAMENTE Y 6. LOS TAMPONES PREFERENTES SON LOS QUE CONTIENE CITRATO Y/O FOSFATO. TAMBIEN SE PRESENTA UN RECEPTACULO HERMETICAMENTE CERRADO LLENADO CON LA COMPOSICION, UN CONJUNTO QUE INCLUYE EL RECEPTACULO Y UNA BOMBA DE PULVERIZACION, Y EL USO DE LA COMPOSICION, DEL RECEPTACULO Y DEL CONJUNTO EN EL CONTROL DE TRASTORNOS URINARIOS.
ES94920618T 1993-06-29 1994-06-22 Composiciones para la administracion de desmopresina por via nasal. Expired - Lifetime ES2158898T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8489493A 1993-06-29 1993-06-29

Publications (1)

Publication Number Publication Date
ES2158898T3 true ES2158898T3 (es) 2001-09-16

Family

ID=22187889

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94920618T Expired - Lifetime ES2158898T3 (es) 1993-06-29 1994-06-22 Composiciones para la administracion de desmopresina por via nasal.

Country Status (20)

Country Link
US (1) US5498598A (es)
EP (1) EP0708657B1 (es)
JP (1) JPH09502425A (es)
KR (1) KR100193104B1 (es)
CN (1) CN1101701C (es)
AT (1) ATE203412T1 (es)
CA (1) CA2166312C (es)
CZ (1) CZ282456B6 (es)
DE (1) DE69427820T2 (es)
DK (1) DK0708657T3 (es)
ES (1) ES2158898T3 (es)
GR (1) GR3036936T3 (es)
HK (1) HK1000906A1 (es)
HU (1) HU221617B1 (es)
NZ (1) NZ268442A (es)
PL (1) PL176317B1 (es)
PT (1) PT708657E (es)
RU (1) RU2135204C1 (es)
SK (1) SK282844B6 (es)
WO (1) WO1995001183A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT710243E (pt) * 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP2001233787A (ja) 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
EP2197532A1 (en) 2007-08-06 2010-06-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
CN101372504B (zh) * 2007-08-22 2011-05-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素的方法
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
WO2009143356A1 (en) 2008-05-21 2009-11-26 Ferring International Center S.A. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US20100160214A1 (en) * 2008-12-22 2010-06-24 Serenity Pharmaceuticals Corporation Desmopressin composition
WO2010075266A2 (en) * 2008-12-22 2010-07-01 Serenity Pharmaceuticals Corporation Safe desmopressin administration
AU2010260211B2 (en) * 2008-12-22 2016-04-21 Acerus Pharmaceuticals USA, LLC Safe desmopressin administration
AU2015261630B2 (en) * 2008-12-22 2017-09-14 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
CN102440957B (zh) * 2011-12-16 2013-09-25 深圳市健元医药科技有限公司 醋酸特利加压素鼻腔喷雾剂及其制备方法
AU2015370666B2 (en) 2014-12-22 2020-09-03 Arovella Therapeutics Limited Prevention and treatment of metastatic disease in thrombocytotic cancer patients
WO2024105521A1 (en) * 2022-11-17 2024-05-23 Shilpa Medicare Limited Stable peptide pharmaceutical composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
WO1988005661A1 (en) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Vasopressin-based pharmaceutical compositions
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
DE69010518T2 (de) * 1989-01-30 1994-11-03 Corint Ltd Wässerige Desmopressin-CMC enthaltende Arzneizubereitung.
EP0432431B1 (en) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient

Also Published As

Publication number Publication date
DK0708657T3 (da) 2001-10-15
HU9503833D0 (en) 1996-02-28
CZ339095A3 (en) 1996-09-11
WO1995001183A1 (en) 1995-01-12
CA2166312C (en) 2002-04-23
US5498598A (en) 1996-03-12
EP0708657B1 (en) 2001-07-25
CN1126439A (zh) 1996-07-10
JPH09502425A (ja) 1997-03-11
CA2166312A1 (en) 1995-01-12
HU221617B1 (hu) 2002-12-28
CN1101701C (zh) 2003-02-19
CZ282456B6 (cs) 1997-07-16
SK282844B6 (sk) 2002-12-03
NZ268442A (en) 1996-09-25
HK1000906A1 (en) 2002-03-08
KR960703339A (ko) 1996-08-17
DE69427820T2 (de) 2001-11-08
KR100193104B1 (ko) 1999-06-15
RU2135204C1 (ru) 1999-08-27
SK165095A3 (en) 1996-11-06
EP0708657A1 (en) 1996-05-01
PT708657E (pt) 2001-11-30
ATE203412T1 (de) 2001-08-15
HUT73776A (en) 1996-09-30
GR3036936T3 (en) 2002-01-31
DE69427820D1 (de) 2001-08-30
PL176317B1 (pl) 1999-05-31
PL312204A1 (en) 1996-04-01

Similar Documents

Publication Publication Date Title
ES2158898T3 (es) Composiciones para la administracion de desmopresina por via nasal.
HK1000903A1 (en) Stabilized pharmaceutical peptide compositions
MD1699F2 (ro) Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei
AU3183389A (en) Human relaxin formulation
HU9602720D0 (en) Improved anti-dandruff shampoo
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
AR018526A1 (es) COMPOSICION FARMACEUTICA NO LIOFILIZADA EN FORMA DE SOLUCIoN QUE COMPRENDE LA HORMONA PARATIROIDEA HUMANA, PROCESO PARA PREPARA UN FRASCO O CARTUCHO QUE LA CONTIENE, PROCESO PARA PREPARAR DICHA COMPOSICIoN, FRASCO O CARTUCHO QUE CONTIENE LA COMPOSICIoN Y USO DE LA MISMA PARA LA FABRICACIoN DE UN MED
CA2308513A1 (en) Method and composition for delivering zinc to the nasal membrane
HUT64567A (en) Method for producing new cyclosporines and preparations containing said compounds as active agent
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
HU9501801D0 (en) Lactame-compounds as pharmaceutical active component
BG103306A (en) Liquid allendronate compositions
NZ337798A (en) Pharmaceutical compositions containing lamivudine
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
UA42722C2 (uk) Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
AU6520196A (en) Aqueous compositions containing ciprofloxacine, and related use and process
IE840977L (en) Pharmaceutical preparations
HK1006282A1 (en) Novel liquid compositions based on derivatives of 1, 4 substituted piperidine
RU94010496A (ru) Ноотропное средство и лекарственный состав ноотропного средства
WO2001023366A3 (en) Vasopressin antagonist and diuretic combination
CA2187030A1 (en) Improved anti-dandruff shampoo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708657

Country of ref document: ES